Dr. Barry Sears Dr. Sears Comments:

I have had the chance to read the paper in detail.  Very sloppy work in defining the fish oil used and ignoring the limited lifetime 16:4 n-3 as a degradation product.  What the author of Time article failed to mention is that in clinical studies when patients were given the same cancer drug used in the mouse study as well as additional omega-3 fatty acids, the survival rate of those getting the drug and omega-3 fatty acids was greater than those getting only the drug.  A very inconvenient fact.